<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-9BVPRX7X</identifier><date>2018</date><creator>Unk, Mojca</creator><creator>Vrankar, Martina</creator><relation>documents/doc/9/URN_NBN_SI_doc-9BVPRX7X_001.pdf</relation><relation>documents/doc/9/URN_NBN_SI_doc-9BVPRX7X_001.txt</relation><format format_type="issue">4</format><format format_type="volume">52</format><format format_type="type">article</format><format format_type="extent">str. 365-369, I</format><identifier identifier_type="ISSN">1318-2099</identifier><identifier identifier_type="COBISSID">3000699</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-9BVPRX7X</identifier><language>eng</language><publisher>Association of Radiology and Oncology</publisher><source>Radiology and oncology (Ljubljana)</source><rights>BY</rights><subject language_type_id="slv">atipičen odgovor</subject><subject language_type_id="slv">imunoterapija</subject><subject language_type_id="slv">pljuča</subject><subject language_type_id="slv">rak (medicina)</subject><title>Immune RECIST criteria and symptomatic pseudoprogression in non-small cell lung cancer patients treated with immunotherapy</title></Record>